HCP Plastene Bulkpack Intrinsic Value
HCP Plastene Bulkpack intrinsic value. HCP Plastene Bulkpack (HPBL) median intrinsic value is ₹375.36 from 8 valuation models (range ₹97–₹465), vs current price ₹314.80 — +19.2% upside (Trading Below Median Value), margin of safety 16.1%. Read HPBL dividend track record for the complete payout history and dividend yield track record.
HPBL Valuation Methods Summary — DCF, Graham Number & P/E
HCP Plastene Bulkpack intrinsic value across 8 models vs current price ₹314.80 — upside/downside and value range per method. Compare with HPBL fundamental valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹375.36 | ₹300.29 - ₹450.43 | +19.2% | EPS: ₹31.28, Sector P/E: 12x |
| Book Value Method | asset | ₹97.27 | ₹87.54 - ₹107.00 | -69.1% | Book Value/Share: ₹97.27, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹421.82 | ₹379.64 - ₹464.00 | +34.0% | Revenue/Share: ₹527.27, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹392.73 | ₹353.46 - ₹432.00 | +24.8% | EBITDA: ₹72.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹200.19 | ₹180.17 - ₹220.21 | -36.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹257.75 | ₹231.97 - ₹283.53 | -18.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹465.45 | ₹418.90 - ₹512.00 | +47.9% | ROE: 29.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹194.55 | ₹175.10 - ₹214.01 | -38.2% | EPS: ₹31.28, BVPS: ₹97.27 |
HPBL Intrinsic Value vs Market Price — All Valuation Models
HCP Plastene Bulkpack fair value range ₹97–₹465 vs current market price ₹314.80 across 8 valuation models. For current market price and key ratios, visit HCP Plastene Bulkpack stock price NSE.
HPBL Intrinsic Value Analysis — Undervalued or Overvalued?
HCP Plastene Bulkpack median intrinsic value ₹375.36, current price ₹314.80 — Trading Below Median Value by 19.2%, margin of safety 16.1%.
What is the intrinsic value of HPBL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of HCP Plastene Bulkpack (HPBL) is ₹375.36 (median value). With the current market price of ₹314.80, this represents a +19.2% variance from our estimated fair value.
The valuation range spans from ₹97.27 to ₹465.45, indicating ₹97.27 - ₹465.45.
Is HPBL undervalued or overvalued?
Based on our multi-method analysis, HCP Plastene Bulkpack (HPBL) appears to be trading below median value by approximately 19.2%.
HPBL Financial Health — Key Ratios vs Industry Benchmarks
HCP Plastene Bulkpack financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.55 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 29.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.53x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
HPBL Cash Flow Quality — Operating & Free Cash Flow
HCP Plastene Bulkpack operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-19 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-20 Cr | ₹-27 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-19 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-20 Cr | ₹-27 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-23 Cr | ₹-52 Cr | Negative Cash Flow | 3/10 |